Enhancing Clinical Trials

Enhancing the clinical trial capabilities within Africa is essential to augment the continent's pandemic prevention, preparedness and response efforts. Here, we ...

Improving Representation in Clinical Trials and Research

Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups. Washington, DC: The National Academies ...

Full article: Toward Enhancing Clinical Trial Diversity

Clinical trials are considered the gold standard for biomedical research, and they are the preferred method to support the safety and ...

Enhancing Efficiency and Inclusivity through Diversified Clinical Trials

While clinical research is at the forefront of critical medical advancements, traditional ways of conducting trials come with significant challenges.

Enhancing Patient Retention in Clinical Trials—Strategies for Success

Up to 25% of cancer trials fail to have complete accrual, and 18% close with less than 50% target accrual after 3 or more years.

Six Key Insights from Global Patient Surveys - Applied Clinical Trials

Enhancing Patient Experience in Clinical Trials: Six Key Insights from Global Patient Surveys. November 5, 2024. By Rebecca Starkie. News. Article.

Enhancing Diversity and Equity in Clinical Trials - UNC Lineberger

The CREATE initiative at UNC Lineberger works to increase awareness about the importance of cancer clinical trials.

How to Enhance DEI in Clinical Trials - Pharmaceutical Executive

Integrating DEI strategies into clinical trials is both crucial for advancing biomedical knowledge and for bolstering trust and equitability ...

Recommendations from the Clinical Trials Transformation Initiative

The recommendations focus on strengthening four key categories of site-based research activity: developing site-based research infrastructure and staff.

Diversity in Our Clinical Trials | Pfizer

The more diverse a group of clinical trial participants is, the more we can learn about the safety and efficacy of a potential medicine or vaccine.

Regulatory reform in China enhancing clinical trials review and ...

The new IND review procedure marks China's formal approval system change from an examination and approval system to tacit permission. It is ...

Enhancing New Zealand Clinical Trials - The University of Auckland

Enhancing New Zealand Clinical Trials is a scoping review of clinical trial infrastructure in New Zealand that is looking to outline an infrastructure ...

Enhancing Adoption of Innovative Clinical Trial Approaches - Day 1

To keep pace with the ever-changing drug development landscape, the U.S. Food and Drug Administration (FDA)'s Center for Drug Evaluation and ...

Promoting diversity in clinical trials: insights from planning the ...

Diversity, equity, and inclusion in clinical trials: a practical guide from the perspective of a trial sponsor

Enhancing Clinical Research through Community Engagement

Community engagement in clinical research is a multifaceted process. Firstly, it necessitates establishing a robust, two-way communication ...

FDA Issues Guidance Intended to Diversify and Enhance Clinical ...

The United States has made significant strides in clinical trial research over the past several decades. However, it is often the case that the ...

Increasing Racial and Ethnic Diversity in Cancer Clinical Trials

1b: Clinical practices and research sites should screen every patient for clinical trials ... clinicians: Enhancing minority participation in clinical trials ( ...

How to Make Clinical Trials More Diverse and Inclusive - ACRP

... research professionals and participants. To learn more about enhancing representation in clinical trials, check out our eBook on DCTs for ...

Faster Together, Enhancing the Recruitment of ... - Coursera

Next, we explore community engagement principles, effective communication strategies, ways to increase community knowledge and awareness of clinical research, ...

HHS Actions to Enhance Diversity in Clinical Research - ASPE

9 However, some research areas such as cardiovascular disease still suffer from a lack of women in clinical trials, and gaps remain for ...